Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > MOA > Flashcards

MOA Flashcards

1
Q

Ramipril
Lisinopril

A

Limits conversion of Angiotensin I to Angiotensin II by inhibiting circulating and tissue ACE

-> reduction in Angiotensin II activity ->
- vasodilation (reduces peripheral resistance & afterload
- reduced aldosterone release (increased Na & water excretion)
- reduced vasopressin (ADH) release (increased water excretion)
- reduced cell growth and proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Losartan
Candesartan

A

Selective inhibition of angiotensin II by competitive antagonism of the angiotensin II receptors

Directly targets AT1 receptors which is more effective at inhibiting Angiotensin II mediated vasoconstriction than ACEi

AT1 receptors are important in CVS regulation but also antagonises AT2 receptors

No effect on bradykinin, dry cough and angioedema much less likely than with ACEi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amlodipine
Nifedipine
Nimodipine

A

Dihydropyridine Ca Channel Blockers are selective for peripheral vasculature with little chronotropic or ionotropic effects - Acts primarily on vascular smooth muscle

CCBs are often 1st choice antihypertensive in pts with low renin

Amlodipine has a long half life

Cerebral vs peripheral selectivity
Nimodipine is selective for cerebral vasculature - useful for ischaemic effects of SAH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Verapamil

A

Prolongs AP/effective refractory period

Less peripheral vasodilation, -ve chronotropic and ionotropic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diltiazem

A

Inhibits the inflow of calcium ions into the cardiac muscle during depolarization. Reduced intracellular calcium concentrations increase smooth muscle relaxation, resulting in arterial vasodilation and decreased blood pressure.

Action in between phenylalkamines and dihydropyridine CCBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bendroflumethiazide
Indapamide

A

Inhibits Na+/Cl- co-transporter in distal convoluted tubule -> decreases Na+ and water reabsorption (RAAS compensates with time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Spironolactone
Eplerenone

A

Aldosterone antagonist -> reduced ENaC (and Na/K/ATPase) expression in late DCT and collecting duct -> decreased Na+ uptake and therefore water
K sparing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bisoprolol
Labetalol
Metoprolol

A

Decrease sympathetic tone by blocking NA and reducing myocardial contraction
resulting in reduced cardiac output

Suppresses renin secretion (β1 on JG cells) -> antihypertensive

Cardiac effects:
- Increases AP duration and refractory period in AV node to slow AP conduction velocity
- Reduce phase 4 depolariasation
- Lowers BP

Effects on ECG:
- Increase PR interval
- Reduce HR - less automacitity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Doxazosin

A

Selective antagonism of α-1 adrenoceptors
Reduces peripheral vascular resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tamsulosin

A

Highly selective antagonism of the urinary tract α-1 adrenoceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Furosemide
Bumetanide

A

Inhibits the N+/K+/2Cl- co-transporter
Reduces N+/K+/2Cl- into epithelium -> water follows
Direct dilation of capacitance veins - reduces preload (likely primary benefit in HF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Amiloride

A

Blocks ENaC channels
Reduces Na+ reabsorption in DTC and reduces K+ excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mannitol

A

Remains in tubular lumen, increases osmotic pull -> water follows in proximal tubule and descending limb and excreted in urine
Can lead to hyperNa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sacubitril

A

Inhibits natriuretic inactivating enzyme -> potentiates effects of ANP/BNP -> natriuresis (Na loss)
Stops breakdown of bradykinin -> vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Atorvastatin
Simvastatin

A

Competitive inhibition of HMG-CoA reductase (rate controlling enzyme in HMG-CoA to mevalonate pathway)
- contributes to upregulation of LDL receptors
-> increased clearance of circulating LDL

Undergo Phase I metabolism by the CYP3A4 isoenzyme (substrate) - not all statins are the same CYP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fenofibrate

A

Activation of nuclear transcription factor - PPARalpha
regulates expression of genes that control lipoprotein metabolism - increases production of lipoprotein lipase

Main effects:
- increased removal of triglycerides from lipoprotein in plasma
- increased fatty acid uptake by liver
Other effects:
- increased levels of HDL
- increased LDL affinity for receptor

Rarely used alone, co-prescribed with statins in mixed hyperlipidaemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ezetimibe

A

Inhibits NPC1L1 transporter at brush border of small intestine
Reduces cholesterol absorption in the gut by ~50%
Hepatic LDL receptor expression increases
Reduction in total cholesterol by ~15% and LDL by ~20%

Prodrug - hepatic metabolism -> enterohepatic circulation which limits systemic exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alirocumab
Evolocumab

A

Inhibits action of PCSK9 (normally binds to LDL-R directing it for degredation) which significantly reduces LDL cholesterol level in primary hyperlipidemia

Not routinely used as still very expensive and must be injected sub-cut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Inclisiran

A

siRNA - inhibits hepatic translation of PCSK9 (normally binds to LDL-R directing it for degredation) so less is produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lidocaine
Mexiletine

A

IV Lidocaine
PO Mexiletine - swap to this after multiple lidocaine doses -> preventative

Effects on cardiac activity:
- Fast binding offset kinetics so need to keep giving frequently
- No change in phase 0 in normal tissue (no tonic block)
- AP duration slightly decreased in normal tissue
- increase threshold for Na+
- AP decreased in phase 0 conduction in fast beating (VT) or ischaemic tissue

Effects on ECG:
- None in normal heart
- Increased QRS in fast beating (VT) or ischaemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Flecainide
Propafenone

A

Propafenone less used

Effects on cardiac activity:
- Substantially decreases phase 0 by blocking Na+ channels in normal
- reduces automaticity by increasing threshold
- increases AP duration (K+) and refractory period esp. in rapidly depolarising atrial tissue e.g. in A fib or Atrial flutter

Effects on ECG:
- prolonged PR, QRS and QT interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Amiodarone

A

Prolong repolarization

Cardiac effects:
- increases refractory period and AP duration by affecting K+ channels
- reduces phase 0 and conduction through Na+ channels
- increase AP threshold
- decreases phase 4
- decreases speed of AV conduction

Effects on ECG:
- increases PR, QRS, QT intervals
- reduces HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Verapamil
Diltiazem

A

Calcium channel blockers

Cardiac effects:
- slows conduction through AV by affecting Ca2+ intake
- increases refractory period in AV node
- increases slope of phase 4 in SA node to slow HR

Effects on ECG:
- Increase RP interval
- Mainly reduce HR but can increase depending on BP response and baroreflex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Adenosine

A

Rapid IV bolus, T1-2 seconds

Cardiac effects:
- decreased HR
- decreased Ca2+ currents -> increased refractory period in AV node
- stops heart for ~10s

Impending doom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Digoxin

A

Enhances vagal activity - increasing refractory period
Slows AV conduction and HR

Reduces ventricular rates in A fib and A flutter

Rarely used as dependant on renal function - if low can lead to bradycardia and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Atropine

A

Selective muscarinic antagonist

Blocks vagal activity to speed up AV conduction and increase HR

Treats vagal bradycardia (helps with fainting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Ivabradine

A

Blocks funny current in SAN
Slows SAN but does not affect BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Tiotropium

A

Blocks muscarinic ACh R in airway smooth muscle
Prevents vaguely mediated contraction

Side effects: anticholinergic effects e.g. dry mouth/eyes, urinary retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Sotalol

A

Prolong repolarization

Cardiac effects:
- Increased AP duration and refractory period in both atrial and ventricular tissue
- Slow phase 4 (beta blocker action too)
- Slows AV conduction

Effects on ECG:
- prolongs QT interval
- reduce HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Alteplase

A

Converts plasminogen to the proteolytic enzyme plasmin, which lyses fibrin as well as fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Anaesthetics

A

Can be local or general
General anaesthetic is normally inhaled or IV

  • Anaesthetic drugs bind to the GABA receptor to potentiate the action of GABAA. GABAA is a major inhibitory neurotransmitter. This leads to the anaesthetic state of unconsciousness, muscle relaxation and analgesia.
  • Anaesthetic drugs also work by opening K+ channels that modulate neuro-excitability. Opening these channels reduce membrane excitability. (Remember your action potential curve where Na+ goes in and K+ goes out. Opening K+ channels will lead to more negative resting potential, making it more difficult to start an action potential).
  • Anaesthetic drugs inhibit opening of ligand-gated ion channels that allow Na+ to enter the cell.
32
Q

Propofol

A

Propofol is a general anaesthetic given intravenously. It is often used as an induction agent and in intensive care for ventilated patients. Propofol decreases the rate of dissociation of GABA from its receptor, which increases the duration of the GABA-activated opening of the chloride channel leading to hyperpolarization of cell membranes. This leads to increased inhibitory tone in the central nervous system. There is pain on injection (due to activation of the pain receptor transient receptor potential ankyrin 1 - TRPA1).

33
Q

Thiopental

A

Thiopental is a general anaesthetic given intravenously. It is a type of barbiturate that works by decreasing neuronal activity which decreases cerebral metabolic rate of oxygen consumption and decreases the cerebrovascular response to carbon dioxide, which will decrease intracranial pressure. It is very lipid-soluble so affects the brain quickly but can also cause laryngospasm.

34
Q

Halothane

A

Halothane is an inhaled general anaesthetic which works by activating Gamma-aminobutyric acid (GABA) and glycine receptors, antagonising N-methyl-D-aspartate (NMDA) receptors and inhibiting voltage gates sodium channels and twin pore potassium channels. This leads to depressed nerve conduction, breathing and cardiac contractility. Adverse effects include hepatotoxicity, myocardial depression and malignant hyperthermia.

35
Q

Atypical anti-psychotics e.g.
Clozapine
Risperidone
Olanzapine
Quetiapine
Aripiprazole

A

5HT2 and D2 receptor antagonists

Antagonising dopamine D2 receptors in the mesolimbic pathway blocks dopamine from acting at post-synaptic receptors. The binding is dissociable so some dopamine neurotransmission still takes place. Action on the serotonin 5HT2A receptors in the frontal cortex decreases adverse effects (compared to typical antipsychotics).

36
Q

Carbamazepine

A

Carbamazepine is chemically similar to the tricyclic antidepressants. It binds to voltage-dependent sodium channels and increases their refractory period, thus preventing the action potential. It is used in epilepsy and bipolar disorder.

Can cause hyponatraemia. Carbamazepine acts on voltage-dependent sodium channels which carry inward membrane current. This reduces the likelihood of the delopment of an action potential

P450 enzyme inducer

37
Q

Amitriptyline

A

Tricyclic antidepressants (TCAs) inhibit a membrane pump mechanism responsible for the re-uptake of transmitter amines (e.g noradrenaline/serotonin) into the presynaptic cleft. Thus, their concentration at the synaptic clefts is increased, and they restimulate post-synaptic receptors. Noradrenaline and serotonin are important in regulating mood, and their increased concentration in the synaptic cleft helps to reduce depressive symptoms.

38
Q

Bleomycin
Teicoplanin
Vancomycin

A

Glycopeptides target the bacterial cell wall by binding to acyl-D-alanyl-D-alanine in peptidoglycan. This prevents the addition of new units to the peptidoglycan in the cell wall.

39
Q

Tamoxifen

A

Tamoxifen is a selective oestrogen receptor modulator (SERM) which acts partially as an oestrogen receptor antagonist, blocking oestrogen from binding to breast cancer cells causing them to grow and divide, and a partial agonist in tissues such as the uterus and bones.

40
Q

Metformin

A

Reduces hepatic glucose production by inhibiting gluconeogenesis

Limited weight gain - supresses appetite

41
Q

Gliclazide

A

Stimulates beta cell pancreatic insulin secretion
(needs residual pancreatic function)

Risk of hypoglycaemia

Weight gain - anabolic effects of insulin

42
Q

Dapagliflozin

A

Reduces glucose absorption from tubular filtrate
Increases urinary glucose excretion

Modest weight loss

Low risk of hypoglycaemia

Increases risk of uti

43
Q

Semaglutide

A

GLP-1 receptor agonist

Increases glucose dependent synthesis of insulin secretion from beta cells
Activates GLP-1 receptor
Resistant to degradation by DPP-4

Subcut injection

Promotes satiety - GLP-1 reduces peristalsis in the gut

44
Q

Aspirin

A

COX-1 inhibitor

Prevents COX-1 mediated production of TXA2 and irreversibly reduces platelet aggregation

Platelet lifespan is 7-10 days

Avoid in children <16 years old due to Reye’s syndrome and pregnancy 3rd trimester due to premature closure of ductus arteriosus

High dose inhibits endothelial prostacyclin (PGI2)

45
Q

Clopidogrel

A

Acts independently of COX pathway

Inhibits binding of ADP to P2Y12 receptor
-> inhibits activation of GPIIb/IIIa receptors

Irreversible inhibitor of P2Y12

Prodrug -> CYP inhibitors e.g. omeprazole reduce efficacy

Hepatic metabolism

46
Q

Ticagreglor

A

Acts independently of COX pathway

Reversible inhibitor of P2Y12

Rapid onset of action compared to clopidogrel

47
Q

Alteplase

A

Fibrinolytic (clot buster)
Dissolve the fibrin meshwork of thrombus

Activate plasmin (plasminogen -> plasmin -> increased fibrinolysis)

48
Q

Streptokinase

A

Fibrinolytic (clot buster)
Dissolve the fibrin meshwork of thrombus

Activate plasmin (plasminogen -> plasmin -> increased fibrinolysis)

Can only be used once as antibodies develop

49
Q

Transexamic acid (TXA)

A

Inhibits fibrinolysis

Stops bleeding

50
Q

Celecoxib

A

Selective COX-2 inhibitor
No antiplatelet action but inhibits PGI2

Less analgesic affect but useful in sever osteo/RA long term

All NSAIDs increase risk of MI including in low risk people (reduced PGI2 protective function)

NSAIDs displace other bound drugs -> increase free drug conc e.g. supfonurea -> hypoglycaemia, methotrexate -> hepatotoxicity, warfarin -> increased risk of bleeding

51
Q

Paracetamol

A

MOA is unknown
non-NSAID, non-opiate analgesic and antipyretic

Risk of overdose
Paracetamol -> NAPQI (conjugated by glutathione -> harmless metabolite
Treat OD with N-acetylcysteine (glutatione replacement)

52
Q

Opiates:
Codeine
Fentanyl
Morphine
Tramadol

A

CNS depressant

Binds to opioid receptor Gai (AC cAMP)

Decreased Ca2+ influx in presynaptic terminal in response to incoming AP
Decreases release of excitatory neurotransmitters e.g. glutamate

Also dampens response to excitatory neurotransmitters at post-synaptic neuron (increases K+ efflux)

In OD use naloxone

53
Q

Gaviscon

A

Antacid - buffers stomach acid
Alginic acid - increases stomach content viscosity and reduces reflux

Magnesium salts -> diarrhoea
Aluminium salts -> constipation
Balanced

54
Q

Omeprazole

A

PPI
Irreversibly inhibits the H+/K+ ATPase in gastric parietal cells
Significantly reduces acid secretion

55
Q

Ranitidine

A

H2 receptor antagonist - competitive inhibition in gastric parietal cells

56
Q

Lactulose

A

Osmotic laxative
Draws fluid into bowel

57
Q

Macrogols

A

Osmotic laxative
Limits loss of fluid from stool

58
Q

Metaclopramide

A

Anti-emetic, D2 receptor antag
Increases intestinal motility (prokinetic)

59
Q

Hyoscine hydrobromide

A

Muscularinic receptor antag
Competitive inhibition of muscularinic ACh receptors

Some action through central trigger zone (via CN8)

Sedative effect

60
Q

Meropenem

A

Inhibits bacterial cell wall synthesis (stops building and repairing)
Very broad spectrum
Generally safe in penicillin allergy

61
Q

Vancomysin

A

Inhibits bacterial cell wall synthesis
Generally gram +ve

62
Q

Flucloxacillin

A

Inhibits bacterial cell wall synthesis

63
Q

Metronidazole

A

Antibiotic, MOA not fully understood but affects bacterial nucleic acid synthesis
Can’t take with alcohol

64
Q

Gentamycin

A

Inhibits bacterial protein synthesis - acts on ribosomes

Profound activity against gram -ve

Nephrotoxic, ototoxic

65
Q

Ceftriaxone

A

Inhibits bacterial cell wall synthesis

66
Q

Aciclovir

A

Inhibits viral DNA polymerase

67
Q

Oseltamivir

A

Viral neuraminidase enzyme inhibitor
- Prevents budding from the host cell, viral replication, and infectivity

68
Q

Amoxicillin

A

Inhibits bacterial cell wall synthesis

69
Q

Trimethoprim

A

Dihydrofolate inhibitor

Interferes with folate synthesis -> inhibits bacterial DNA synthesis

Avoid in pregnancy (1st trimester) -> neural tube defects

70
Q

Nitrofurantoin

A

Own class
Converted by bacterial nitroreductases to electrophilic intermediates which inhibit the citric acid cycle as well as synthesis of DNA, RNA, and protein.

71
Q

Doxycycline

A

Inhibits bacterial protein synthesis - acts on ribosomes

72
Q

Co-amoxiclav

A

Beta-lactam antibiotic (inhibits cell wall synthesis) +
Clavulanic acid - beta-lactamase inhibitor, stops bacteria inhibiting antibiotic

73
Q

Clarythromycin

A

Inhibits bacterial protein synthesis - acts on ribosomes

74
Q

Erythromycin

A

Inhibits bacterial protein synthesis - acts on ribosomes

75
Q

Azithromycin

A

Inhibits bacterial protein synthesis - acts on ribosomes

76
Q

Ofloxacin

A

Inhibiting two enzymes involved in bacterial DNA synthesis (DNA topoisomerase)

Pharmacology (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions